Table 1.
Demographic characteristics and baseline data of the study population
| OMJ (N = 30) | GC (N = 26) | p value | |
|---|---|---|---|
| Sex, N (%) | 0.346C | ||
| Male | 22 (73.3) | 16 (61.5) | |
| Female | 8 (26.7) | 10 (38.5) | |
| Age (years, average + SD) | 55.8 ± 9.3 | 56.9 ± 10.7 | 0.706T |
| Cancer location, N (%) | 0.755F | ||
| Nasopharynx | 10 (33.3) | 10 (38.5) | |
| Oral cavity | 10 (33.3) | 6 (23.1) | |
| Tongue | 5 (16.7) | 5 (19.2) | |
| Larynx | 3 (10) | 2 (7.7) | |
| Oropharynx | 2 (6.7) | 1 (3.9) | |
| Others | 0 | 2 (7.7) | |
| Type of radiation, N (%) | 0.920C | ||
| 2-dimensional | 20 (66.7) | 17 (65.4) | |
| 3-dimensional | 10 (33.3) | 9 (34.6) | |
| Duration after radiotherapy, N (%) | 0.791F | ||
| Less than 6 months | 5 (16.7) | 3 (11.5) | |
| 6 months to 1 year | 5 (16.7) | 6 (23.1) | |
| 1 year and more | 20 (66.7) | 17 (65.4) | |
| Denture use, N (%) | 6 (20.0) | 6 (23.1) | 0.780C |
| Antifungal use within 1 year, N (%) | 2 (6.7) | 4 (15.4) | 0.401F |
| Antibiotic use within 1 month, N (%) | 5 (16.7) | 7 (26.9) | 0.351C |
| Subjective dry mouth score | 5.4 ± 1.5 | 5.1 ± 1.5 | 0.520T |
| Salivary flow rates (μl/min) | 80.2 ± 114.4 | 49.1 ± 66.5 | 0.274M |
| Saliva pH | 6.5 ± 0.8 | 6.3 ± 0.9 | 0.322T |
| Saliva buffering capacity | 4.0 ± 0.9 | 4.1 ± 1.1 | 0.808T |
| Candida carriers, N (%) | 27 (90) | 21 (80.8) | 0.451F |
FBy Fisher’s exact test
CBy Pearson chi-square test
TBy independent t test
MBy Mann-Whitney U test
*Statistically significant difference (p < 0.05)